Harvard Medical School, Boston (United States of America)
0
follower
5
more
presentations
in this session
Cost-effectiveness of apixaban vs aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial
Should body mass index categories differ by ethnicity? All-cause mortality and incident cardiovascular disease in a multi-ethnic cohort of 400,000 adults
External validation of the ISARIC-4C mortality risk prediction score in patients hospitalized with COVID-19: Retrospective analysis of the World Heart Federation (WHF) COVID-19 Global Study